Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

If I Could Only Buy One AI Stock Before 2027, It Would Be This Onefool.com
This stock is a great choice for cautious and aggressive investors.
Via The Motley Fool · October 6, 2026
The 2 Best Nasdaq-100 Stocks to Buy Now, According to Wall Streetfool.com
Wall Street says AppLovin and Axon Enterprise are the best Nasdaq-100 stocks to buy now.
Via The Motley Fool · October 6, 2026
Is VOO Still the Best S&P 500 ETF You Can Own? Here's How It Stacks Up Against the Alternatives.fool.com
Warren Buffett once recommended Vanguard's low-cost S&P 500 index funds. But would the "Oracle of Omaha" choose another ETF today?
Via The Motley Fool · October 6, 2026
Cognizant Tech Solutions-A (NASDAQ:CTSH): A Decent Value Stock With Margin of Safetychartmill.com
Via Chartmill · October 6, 2026
BHP Group (NYSE:BHP) Technical Strength Meets Breakout Setupchartmill.com
Via Chartmill · October 6, 2026
Comfort Systems USA (NYSE:FIX) Delivers High Growth and Strengthening Fundamentalschartmill.com
Via Chartmill · October 6, 2026
MONDAY.COM LTD (NASDAQ:MNDY) Surfaces as a Decent Value Stockchartmill.com
Via Chartmill · October 6, 2026
XCF Global Stockholders Approve 1.7B Share Authorization, Business Combination Measuresmarketbeat.com
XCF Global Capital (NASDAQ:SAFX) stockholders approved five proposals at a special meeting, including measures to increase the company’s authorized Class A common stock, authorize potential share issuance tied to a business combination, elect seven post-closing directors and expand the company’s equ
Via MarketBeat · October 6, 2026
Tesla Just Delivered Excellent News, but Is the Stock a Buy?fool.com
Tesla delivered more electric vehicles than expected during the third quarter of 2026.
Via The Motley Fool · October 6, 2026
3 Monster Consumer Stocks to Hold for the Next 20 Yearsfool.com
Strong brands and high dividend returns should make these stocks long-term winners.
Via The Motley Fool · October 6, 2026
Micron Technology (NASDAQ:MU) Delivers High Growth and Improving Fundamentals Across Eight Key Testschartmill.com
Via Chartmill · October 6, 2026
Warren Buffett's Overlooked AI Race Pickfool.com
Alphabet's fundamentals position it better for potential AI market volatility.
Via The Motley Fool · October 6, 2026
Here We Go! President Donald Trump Just Threw Fed Chair Kevin Warsh Under the Bus Over Interest Rates.fool.com
Trump admonished the Fed for raising rates, while ignoring that his own policies are fueling inflation.
Via The Motley Fool · October 6, 2026
Anthropic Is Aiming for the Biggest IPO Ever -- Here's the Chip Stock to Buy Before It Listsfool.com
One chipmaker's shaping up as both the AI lab's supplier and its reported lender.
Via The Motley Fool · October 6, 2026
Social Security’s 2027 COLA Could Be a Classic Good News/Bad News Situationfool.com
If you're on Social Security, you need to know what's coming.
Via The Motley Fool · October 6, 2026
The Overlooked AI Stock Poised to Outperform Nvidia and Palantirfool.com
Without liquid cooling systems like Vertiv's, modern AI data centers wouldn't be possible.
Via The Motley Fool · October 6, 2026
Will Intel Bring Back Its Dividend Now That Its Stock Has Tripled?fool.com
When Intel quit paying shareholders in 2024, it named the condition for restarting. How close is it now?
Via The Motley Fool · October 6, 2026
Nasdaq Hits a Fresh Record While the 10-Year Climbs to 5.31%chartmill.com
Via Chartmill · October 6, 2026
Here's How Many Shares of Nike You'd Need for $10,000 in Yearly Dividendsfool.com
The dominant sportwear maker continues to struggle as it aims to turn the business around.
Via The Motley Fool · October 6, 2026
Monte Rosa's MRT-8102 Shows Biomarker Gains in GFORCE-1 Studymarketbeat.com
Monte Rosa Therapeutics (NASDAQ:GLUE) reported results from GFORCE-1, a Phase I study of its NEK7-directed molecular glue degrader MRT-8102 in participants with elevated cardiovascular risk. The company said the four-week dosing study showed sustained degradation of NEK7, reductions in inflammatory
Via MarketBeat · October 6, 2026
$10,000 in Marvell Stock a Decade Ago Is Worth About $206,000 Now. Repeating That Would Take 35% Annual Earnings Growth.fool.com
Most of the decade's rise came this year. What would it take to do it all over?
Via The Motley Fool · October 6, 2026
Rigetti Computing vs. D-Wave Quantum: Which Quantum Computing Stock Is the Better Buy?fool.com
Both pure plays just received additional government funding and have a few customers.
Via The Motley Fool · October 6, 2026
Inter's 2026 Outlook: Digital Fintech SuperApp Strategy Targets Sustained Growthfool.com
This under-the-radar fintech stock boasts a Superscore of 74 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 6, 2026
Is Vanguard's Growth ETF a Buy at a Record High?fool.com
Ten years of beating the S&P 500 is tough to ignore -- but is it a reason to buy at a record?
Via The Motley Fool · October 6, 2026
Is Taiwan Semiconductor the Best AI Stock to Buy Now?fool.com
Taiwan Semiconductor supplies nearly every competitor in the AI arena with chips.
Via The Motley Fool · October 6, 2026